Dennis Gillings

Place

• Now
  25th
• Last week
  27th
• Two weeks ago
  26th
• Three weeks ago
  26th

Dennis Gillings, a prominent billionaire from the United Kingdom, has made significant contributions to the field of healthcare and pharmaceutical research. With a background in biostatistics, Gillings co-founded Quintiles Transnational Corp. in 1982, which later became QuintilesIMS and is now known as IQVIA. The company specializes in providing integrated information and technology-enabled services to the healthcare industry, focusing on clinical trials, real-world evidence, and consulting services.

Under Gillings' leadership as Chairman and CEO for many years, QuintilesIMS (now IQVIA) grew to become a global leader in its sector, supporting pharmaceutical, biotechnology, and healthcare companies worldwide in their efforts to develop and commercialize new therapies and treatments. His expertise in biostatistics and his visionary approach to healthcare analytics and data-driven insights have played a crucial role in transforming the industry.

Aside from his achievements in business, Dennis Gillings is also recognized for his philanthropic endeavors. He established the Dennis Gillings Foundation, which supports various charitable initiatives focused on healthcare, education, and social welfare globally. His commitment to advancing medical research and improving healthcare outcomes underscores his dedication to making a positive impact on society.

As a billionaire entrepreneur and philanthropist, Dennis Gillings' career exemplifies the intersection of scientific innovation, business acumen, and social responsibility. His pioneering efforts in healthcare analytics and clinical research have set benchmarks in the industry, shaping the future of evidence-based medicine and healthcare delivery worldwide. Gillings' legacy continues to inspire future generations of healthcare professionals and entrepreneurs to innovate and drive positive change in global health outcomes.

Share

Your involvement